Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2729 - 2736 of 12085 results
TCPA Regulatory Update — Senators Introduce Bipartisan Legislation to Enhance Robocall Traceback Efforts
December 27, 2021| Article| Viewpoint
TCPA Litigation Update — District Courts Reach a Consensus on the Impact of Facebook
December 27, 2021| Article| Viewpoint
FDA Issues Draft Device Guidance in Preparation for the End of the Public Health Emergency
December 27, 2021| Blog| Viewpoint
FTC Issues Fines Totaling Nearly $2 Million For Failures To File HSR Notifications
December 27, 2021| Blog| Viewpoint
Supreme Court to Have Final Word on OSHA Vaccine Order
December 23, 2021| Blog| Viewpoint
New York City Updates its Vaccine Executive Order Guidance
December 23, 2021| Blog| Viewpoint
Massachusetts Supreme Judicial Court Rejects Use of Independent Contractor Statute for Joint Employment Status Determination
December 23, 2021| Blog| Viewpoint
New York City Council Passes Salary Range Transparency Law
December 23, 2021| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|